Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Sanofi Completes $600 Million Acquisition of DR-0201 to Enhance Immunology Pipeline and Advance Autoimmune Disease Treatments

(IN BRIEF) Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid cell engager, which has shown promising results in B-cell depletion, may offer potential breakthroughs in autoimmune diseases, … Read the full press release

TreeFrog Therapeutics Secures €30 Million from EIB to Advance Parkinson’s Disease Cell Therapy

(IN BRIEF) TreeFrog Therapeutics has secured €30 million in financing from the European Investment Bank to advance its cell therapy program for Parkinson’s disease and support the development of its internal pipeline targeting diseases with high unmet needs. The funding, … Read the full press release

University of Southampton Researchers to Support Breast Walk Ever in Aid of Breast Cancer Research

(IN BRIEF) Researchers from the University of Southampton will join the Breast Walk Ever charity event on 8 June 2025 to support Against Breast Cancer and raise funds for vital research into secondary breast cancer. ABC-funded PhD student Grace Hayes … Read the full press release

Study Reveals Link Between Teenage Obesity in Fathers and Increased Health Risks in Future Generations

(IN BRIEF) A study from the University of Southampton and the University of Bergen reveals that boys who become overweight during their early teens may inadvertently affect the health of their future children. The research found epigenetic changes in genes … Read the full press release

Technical University of Munich Researchers Discover Mechanism Behind Female-Specific Aging Health Conditions

(IN BRIEF) A team at the Technical University of Munich has uncovered a potential new explanation for sex-based differences in age-related diseases. Their study found that as female mice age, genes on the silenced second X chromosome become active again. … Read the full press release

Eckert & Ziegler Honored with the “Best Managed Companies Award” for Exceptional Leadership and Innovation

(IN BRIEF) Eckert & Ziegler SE has been awarded the “Best Managed Companies Award” for the second time, a prestigious recognition celebrating excellence in strategy, innovation, culture, and governance. This accolade underscores the company’s continued leadership in supplying isotopes for … Read the full press release

Samaritans Ireland’s 2024 Report Reveals High Satisfaction Rates as Volunteers Respond to 470,000 Calls

(IN BRIEF) Samaritans Ireland’s 2024 Impact Report highlights the vital role the charity plays in offering emotional support, with volunteers answering 50 calls per hour on average last year. The report reveals that Samaritans is the only form of support … Read the full press release

CVC Strategic Opportunities Sells Entire Stake in Genetic S.p.A., Strengthening the Company’s Global Position

(IN BRIEF) CVC Strategic Opportunities II has successfully exited its investment in Genetic S.p.A., a pharmaceutical CDMO specializing in Respiratory, Ophthalmic, and Oncology therapeutic products. The exit sees NB Renaissance and NB Aurora joining the Pavese family as shareholders. Under … Read the full press release

Empa Researchers Develop Safe Nanomedicines to Treat Inflammation During Pregnancy

(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release

NIB and Celltechna Collaborate on First Baltics Gene Therapy Centre to Boost Life Sciences Innovation

(IN BRIEF) NIB has financed the Gene Therapy Centre in Lithuania, a groundbreaking facility advancing gene therapy research and manufacturing. Opened in September, it is a critical part of Lithuania’s life sciences sector, contributing to the country’s goal of growing … Read the full press release

WACKER and BENEO Partner to Bring 2’-Fucosyllactose (2’-FL) to European Market for Infant Nutrition

(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release

GSK’s Blenrep Combinations Receive Approval in Japan for Relapsed or Refractory Multiple Myeloma Treatment

(IN BRIEF) GSK has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Blenrep combinations to treat adults with relapsed or refractory multiple myeloma. The approval follows positive results from the DREAMM-7 and DREAMM-8 phase III trials, … Read the full press release

CTP Develops New Sustainable Production Facility for SCHOTT Pharma at CTPark Jagodina, Expanding Global Manufacturing Network

(IN BRIEF) CTP has successfully developed a state-of-the-art 18,000 sqm production facility for SCHOTT Pharma at CTPark Jagodina, Serbia, where high-quality glass ampoules for vaccines and medications will be produced. This facility is a significant addition to SCHOTT Pharma’s global … Read the full press release

University of Copenhagen Researchers Unveil Biosynthetic Method to Cut the Cost of Taxol and Make Production More Sustainable

(IN BRIEF) Researchers from the University of Copenhagen have made a breakthrough in the biosynthetic production of Taxol, a widely used chemotherapy drug. By identifying the enzymes responsible for the final steps in the biosynthetic pathway of Taxol, the team … Read the full press release

SAF Tehnika Combines Wellness and Innovation through Weekly Training Runs, Building Team Spirit and Employee Growth

(IN BRIEF) SAF Tehnika has created a unique company culture by incorporating weekly joint training run sessions, where employees from all departments unite to challenge themselves both physically and mentally. What started as a wellness initiative has grown into a … Read the full press release

OptiSigns anuncia su expansión Europea

OptiSigns ha abierto una nueva oficina en Munich, Alemania y ha añadido liderazgo clave para apoyar mejor a los clientes de la UE OptiSigns es una empresa líder en señalización digital en Norteamérica, con más de 30.500 clientes en 121 … Read the full press release

OptiSigns annonce son expansion européenne

OptiSigns a ouvert un nouveau bureau à Munich, en Allemagne, et a recruté des dirigeants clés pour mieux soutenir les clients de l’UE OptiSigns est la principale entreprise de signalisation numérique en Amérique du Nord, avec plus de 30 500 … Read the full press release

OptiSigns kündigt europäische Expansion an

OptiSigns hat ein neues Büro in München, Deutschland eröffnet und Führungskräfte hinzugefügt, um EU-Kunden besser zu unterstützen OptiSigns ist das führende Digital-Signage-Unternehmen in Nordamerika mit über 30.500 Kunden in 121 Ländern, die ihre Hardware und Software zur Anzeige von Beschilderungen … Read the full press release

OptiSigns Announces European Expansion

OptiSigns has opened a new office in Munich, Germany and added key leadership to better support EU customers OptiSigns is the leading digital signage company in North America, with over 30,500 customers in 121 countries using their hardware and software … Read the full press release

AstraZeneca’s Imfinzi Plus BCG Induction and Maintenance Therapy Significantly Improves Disease-Free Survival in High-Risk Non-Muscle-Invasive Bladder Cancer

(IN BRIEF) The POTOMAC Phase III trial results show that adding Imfinzi to standard BCG induction and maintenance therapy improves disease-free survival (DFS) for patients with high-risk non-muscle-invasive bladder cancer (NMIBC). The combination demonstrated significant benefits over BCG alone, with … Read the full press release